Inventor
Lina Setti
Inventor
Fremont, CA, US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07BGeneral methods of organic chemistry23%
A61KPreparations for medical, dental or toiletry purposes19%
PatentTitleYear
10,709,712Biaryl amide compounds as kinase inhibitors202010,245,267Biaryl amide compounds as kinase inhibitors201910,167,279Compounds and compositions as RAF kinase inhibitors201910,144,746Bridged bicyclic kallikrein inhibitors20189,815,853'Bridged bicyclic kallikrein inhibitors'20179,694,016'Biaryl amide compounds as kinase inhibitors'20179,695,166'Pyrazolopyridine pyrazolopyrimidine and related compounds'20179,242,969'Biaryl amide compounds as kinase inhibitors'20166,642,381'Pyrimido5,4-e1,2,4triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003Patents assigned to HOFFMANN LA ROCHE (1)· patent assignee history
2003Based in San Mateo, CA, US· patent location history
2016–2020Patents assigned to NOVARTIS AG (5)· patent assignee history
2016–2020Based in Fremont, CA, US· patent location history
2017–2018Patents assigned to GLOBAL BLOOD THERAPEUTICS INC (3)· patent assignee history
2017Based in South San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 5 | 2016–2020 |
| GLOBAL BLOOD THERAPEUTICS INC | 3 | 2017–2018 |
| HOFFMANN LA ROCHE | 1 | 2003 |
Locations
| Location | Patents | Span |
|---|---|---|
| Fremont, California, US | 7 | 2016–2020 |
| South San Francisco, California, US | 1 | 2017 |
| San Mateo, California, US | 1 | 2003 |